USP13 and hepatocellular carcinoma: Furthermore, IHC analysis indicated that USP13 positive expression was confirmed in 52 of 80 (65.0%) HCC cases, while only 34 of 80 (42.5%) non-tumor samples showed USP13 positive expression (P = 0.0043, Figure 1B).